Global Biopsy Devices Market to Reach $2.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Biopsy Devices estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. CT Scan-Guided Biopsy, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$729.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Steretactics-Guided Biopsy segment is readjusted to a revised 4% CAGR for the next 7-year period.
![Global Market for Biopsy Devices]( "Global Market for Biopsy Devices")
The U.S. Market is Estimated at $518.8 Million, While China is Forecast to Grow at 4.1% CAGR
The Biopsy Devices market in the U.S. is estimated at US$518.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$420.9 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Ultrasound-Guided Biopsy Segment to Record 4.7% CAGR
In the global Ultrasound-Guided Biopsy segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$243.4 Million in the year 2020 will reach a projected size of US$336.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$272.6 Million by the year 2027.
Select Competitors (Total 46 Featured):
Amid the COVID-19 crisis, the global market for Biopsy Devices estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. CT Scan-Guided Biopsy, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$729.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Steretactics-Guided Biopsy segment is readjusted to a revised 4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $518.8 Million, While China is Forecast to Grow at 4.1% CAGR
The Biopsy Devices market in the U.S. is estimated at US$518.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$420.9 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Ultrasound-Guided Biopsy Segment to Record 4.7% CAGR
In the global Ultrasound-Guided Biopsy segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$243.4 Million in the year 2020 will reach a projected size of US$336.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$272.6 Million by the year 2027.
Select Competitors (Total 46 Featured):
- Argon Medical Devices, Inc.
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Group, Inc.
- FUJIFILM Holdings Corporation
- Hologic, Inc.
- Inrad, Inc.
- Medtronic PLC
- Olympus Corporation
Frequently Asked Questions about the Global Market for Biopsy Devices
What is the estimated value of the Global Market for Biopsy Devices?
The Global Market for Biopsy Devices was estimated to be valued at $1.8 Billion in 2020.
What is the growth rate of the Global Market for Biopsy Devices?
The growth rate of the Global Market for Biopsy Devices is 4.2%, with an estimated value of $2.4 Billion by 2027.
What is the forecasted size of the Global Market for Biopsy Devices?
The Global Market for Biopsy Devices is estimated to be worth $2.4 Billion by 2027.
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Table 1: World Current & Future Analysis for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 2: World Historic Review for Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 3: World 15-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
- Table 4: World Current & Future Analysis for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 5: World Historic Review for CT Scan-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 6: World 15-Year Perspective for CT Scan-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- Table 7: World Current & Future Analysis for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 8: World Historic Review for Steretactics-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 9: World 15-Year Perspective for Steretactics-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- Table 10: World Current & Future Analysis for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 11: World Historic Review for Ultrasound-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 12: World 15-Year Perspective for Ultrasound-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- Table 13: World Current & Future Analysis for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 14: World Historic Review for MRI-Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 15: World 15-Year Perspective for MRI-Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- Table 16: World Current & Future Analysis for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 17: World Historic Review for Other Imaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 18: World 15-Year Perspective for Other Imaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- Table 19: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- Table 22: World Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 23: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 24: World 15-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
- Table 25: USA Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 26: USA Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 27: USA 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 28: USA Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 29: USA Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 30: USA 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 31: Canada Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 32: Canada Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 33: Canada 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 34: Canada Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 35: Canada Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 36: Canada 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 37: Japan Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 38: Japan Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 39: Japan 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 40: Japan Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 41: Japan Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 42: Japan 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 43: China Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 44: China Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 45: China 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 46: China Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 47: China Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 48: China 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 49: Europe Current & Future Analysis for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- Table 50: Europe Historic Review for Biopsy Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 51: Europe 15-Year Perspective for Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
- Table 52: Europe Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 53: Europe Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 54: Europe 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 55: Europe Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 56: Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 57: Europe 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 58: France Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 59: France Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 60: France 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 61: France Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 62: France Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 63: France 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 64: Germany Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 65: Germany Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 66: Germany 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 67: Germany Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 68: Germany Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 69: Germany 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 70: Italy Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 71: Italy Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 72: Italy 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 73: Italy Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 74: Italy Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 75: Italy 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 76: UK Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 77: UK Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 78: UK 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 79: UK Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 80: UK Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 81: UK 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 82: Rest of Europe Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 83: Rest of Europe Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 84: Rest of Europe 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 85: Rest of Europe Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 86: Rest of Europe Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 87: Rest of Europe 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 88: Asia-Pacific Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 89: Asia-Pacific Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 90: Asia-Pacific 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 91: Asia-Pacific Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 92: Asia-Pacific Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 93: Asia-Pacific 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
- Table 94: Rest of World Current & Future Analysis for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 95: Rest of World Historic Review for Biopsy Devices by Imaging Technology - CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 96: Rest of World 15-Year Perspective for Biopsy Devices by Imaging Technology - Percentage Breakdown of Value Sales for CT Scan-Guided Biopsy, Steretactics-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy and Other Imaging Technologies for the Years 2012, 2020 & 2027
- Table 97: Rest of World Current & Future Analysis for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
- Table 98: Rest of World Historic Review for Biopsy Devices by End-Use - Hospitals and Diagnostics Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- Table 99: Rest of World 15-Year Perspective for Biopsy Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostics Centers for the Years 2012, 2020 & 2027
IV. COMPETITION
- Total Companies Profiled: 46
Note: Product cover images may vary from those shown
